D-0943-2017 Class III Terminated
FDA drug recall D-0943-2017 was initiated by Sandoz Incorporated on Jun 16, 2017 and is designated Class III. Reason for recall: Cross Contamination With Other Product: Imipramine The recall status is terminated (terminated Jan 14, 2019). Affected quantity: 38,234 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 12, 2017
- Initiation Date
- Jun 16, 2017
- Termination Date
- Jan 14, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 38,234 bottles
Product description
Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540
Reason for recall
Cross Contamination With Other Product: Imipramine
Distribution pattern
Product was distributed throughout the United States
Code information
Lot #: a) GR3831, GS9690, Exp. 08/2019; b) GR3832, Exp. 08/2019.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0943-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026